To obtain reimbursement for Synvisc-One® and SYNVISC® (hylan G-F 20), you must submit a property coded claim form. Below are the billing codes commonly used for Synvisc-One and SYNVISC and its administration.
Synvisc-One Billing Codes
| ICD-9-CM | |
|
715.16 |
Osteoarthritis, localized, primary, lower leg |
|
715.26 |
Osteoarthritis, localized, secondary, lower leg |
|
715.36 |
Osteoarthritis, localized, unspecified as to primary or secondary, lower leg |
|
715.96 |
Osteoarthritis, localized, unspecified whether generalized or localized, lower leg |
| NDC | |
|
58468-0090-01 |
SYNVSIC |
|
58468-0090-03 |
Synvisc-One |
| HCPCS | |
|
J7325 |
for Synvisc-One and SYNVISC, per 1mg |
|
Synvisc-One |
48 in Units field of CMS-1500 Claim form or electronic equivalent |
|
SYNVISC |
16 in Units field of CMS-1500 Claim form or electronic equivalent |
| CPT | |
|
20610 |
Arthrocentesis, major joint or bursa * Include modifiers -RT, -LT or 50 (bilateral) |
|
99211 to 99215 |
Office visit for established patients |
|
99201 to 99205 |
New patient office or other outpatient visit |
| Revenue Codes (used in hospital setting only) | |
|
R636 |
Drugs requiring detailed coding |
|
510 |
Clinic Visit |
The proper use of medical billing codes is critical for ensuring that your patient’s claims are submitted correctly and represent services rendered. Claim forms should include:
- What drugs or supplies were used
- What procedures were done
- What disease state was treated
Providers are responsible for the selection of appropriate codes depending on clinical diagnosis. Information in the above table provides a general framework for understanding possible coding alternatives. It should not be used as a substitute for a healthcare professional’s own judgment.
Providers retain responsibility for determining reimbursement and insurance issues related to their patients. Genzyme cannot be responsible for failure of a provider to obtain reimbursement.